World's Best Scientists 2026 revealed!
Kenneth R. Chapman

Kenneth R. Chapman

D-Index & Metrics

Medicine

D-Index
89
Citations
25416
World Ranking
12809
National Ranking
523

Overview

Kenneth R. Chapman is affiliated with the University of Toronto in Canada. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine. Throughout their career, they have produced numerous publications, concentrating on various subfields including physiology, anesthesiology and pain medicine, cancer research, and surgery.

The main topics covered in Kenneth R. Chapman's work include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Respiratory Support and Mechanisms
  • Pain Management and Treatment
  • Inhalation and Respiratory Drug Delivery
  • Protease and Inhibitor Mechanisms

They have co-authored extensively with several researchers, among whom the most frequent are:

  • Jean Bourbeau
  • Brandie Walker
  • Wan C. Tan
  • Paul Hernandez
  • François Maltais

Kenneth R. Chapman's publications have appeared in a variety of scientific venues, with a notable frequency in the following journals:

  • Neuromodulation Technology at the Neural Interface
  • American Journal of Respiratory and Critical Care Medicine
  • The Journal of Allergy and Clinical Immunology In Practice
  • CHEST Journal
  • International Journal of COPD

Some recent papers authored by Kenneth R. Chapman include:

  • "Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial" (2020) published in The Lancet Respiratory Medicine
  • "Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study" (2020) published in The Lancet Respiratory Medicine
  • "Defining a Severe Asthma Super-Responder: Findings from a Delphi Process" (2021) published in The Journal of Allergy and Clinical Immunology In Practice
  • "Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial" (2020) published in Bioimpacts
  • "Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic" (2020) published in CHEST Journal

Best Publications

  • Epidemiology and costs of chronic obstructive pulmonary disease.

    K R Chapman;D M Mannino;J B Soriano;P A Vermeire

  • Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

    Jadwiga A Wedzicha;Donald Banerji;Kenneth R Chapman;Jørgen Vestbo

  • Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

    Shawn D Aaron;Katherine L Vandemheen;Dean Fergusson;François Maltais

  • Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.

    Philip E. Silkoff;Patricia A. McCLEAN;Arthur S. Slutsky;Henry G. Furlott

  • Gender Bias in the Diagnosis of COPD

    Kenneth R. Chapman;Donald P. Tashkin;David J. Pye

  • Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

    Nicola A Hanania;Phillip Korenblat;Kenneth R Chapman;Kenneth R Chapman;Eric D Bateman

  • Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

    Kenneth R Chapman;Jonathan G W Burdon;Eeva Piitulainen;Robert A Sandhaus

  • Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response

    Louis Philippe Boulet;Kenneth R. Chapman;Johanne Côté;Sanjay Kalra

  • Suboptimal asthma control: prevalence, detection and consequences in general practice

    K. R. Chapman;L. P. Boulet;R. M. Rea;E. Franssen

  • Minimal clinically important differences in pharmacological trials.

    Paul W Jones;Kai M Beeh;Kenneth R Chapman;Marc Decramer

  • Medical Personnel's Knowledge of and Ability to Use Inhaling Devices: Metered-Dose Inhalers, Spacing Chambers, and Breath-actuated Dry Powder Inhalers

    Nicola A. Hanania;Richard Wittman;Steven Kesten;Kenneth R. Chapman

  • Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

    A.S. Rebuck;K.R. Chapman;R. Abboud;P.D. Pare

  • Adverse effects of inhaled corticosteroids

    Nicola A. Hanania;Kenneth R. Chapman;Steven Kesten

  • Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

    Marc L Decramer;Kenneth R Chapman;Ronald Dahl;Peter Frith

  • A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada.

    Michael Jerrett;Murray M. Finkelstein;Jeffrey R. Brook;M. Altaf Arain

  • Asthma Control in Canada Remains Suboptimal: The Reality of Asthma Control (TRAC) Study

    J Mark FitzGerald;Louis-Philippe Boulet;R Andrew McIvor;Sabrina Zimmerman

  • Adult Asthma Consensus Guidelines Update 2003

    Catherine Lemière;Tony Bai;Meyer Balter;Charles Bayliff

  • Relation between income, air pollution and mortality: a cohort study

    Murray M. Finkelstein;Michael Jerrett;Patrick DeLuca;Norm Finkelstein

  • Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

    Chapman Kr;Hurst;Frent Sm;Larbig M

  • Exhaled nitric oxide as a noninvasive assessment of chronic cough.

    Jose M. Chatkin;Khalil Ansarin;Philip E. Silkoff;Patricia McCLEAN

Frequent Co-Authors

Jean Bourbeau
Jean Bourbeau McGill University
Shawn D. Aaron
Shawn D. Aaron Ottawa Hospital
Denis E. O'Donnell
Denis E. O'Donnell Queen's University
François Maltais
François Maltais Université Laval
J. Mark FitzGerald
J. Mark FitzGerald University of British Columbia
Claus Vogelmeier
Claus Vogelmeier Philipp University of Marburg
Nicola A. Hanania
Nicola A. Hanania Baylor College of Medicine
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha Imperial College London
Noel G. McElvaney
Noel G. McElvaney Royal College of Surgeons in Ireland
Malcolm R. Sears
Malcolm R. Sears McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career isn't limited to traditional, in-person degrees. Many students are exploring online options that offer flexibility, affordability, and diverse career pathways in healthcare. For those interested in administrative roles, pursuing medical coding certification cost is a key consideration, as programs vary widely in price and can lead to job opportunities in hospitals and clinics.

Aspiring nurse practitioners can take advantage of cheap online fnp programs, making advanced practice nursing more accessible than ever. Similarly, if you are looking at entry-level nursing, it’s important to understand how much does online nursing school cost, as tuition and fees can vary significantly.

For those pursuing leadership or research roles, phd nursing programs online can open doors to advanced academic and administrative positions. Exploring these online degrees can help you discover affordable, flexible options that align with your goals in the medical field.

Best Scientists Citing Kenneth R. Chapman

Trending Scientists

Recently Published Articles